Natalie Mount

552 total citations
9 papers, 337 citations indexed

About

Natalie Mount is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Natalie Mount has authored 9 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Natalie Mount's work include CAR-T cell therapy research (3 papers), Biomedical Ethics and Regulation (2 papers) and Pluripotent Stem Cells Research (2 papers). Natalie Mount is often cited by papers focused on CAR-T cell therapy research (3 papers), Biomedical Ethics and Regulation (2 papers) and Pluripotent Stem Cells Research (2 papers). Natalie Mount collaborates with scholars based in United Kingdom, Sweden and Canada. Natalie Mount's co-authors include Michaela Sharpe, Johan Hyllner, Stephen Ward, Panos Kefalas, Stephen C. Phillips, David Howe, Hannah M. Jones, Peter J. Bungay, Karl R. Gibson and Ellen G. Feigal and has published in prestigious journals such as Philosophical Transactions of the Royal Society B Biological Sciences, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Natalie Mount

9 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Mount United Kingdom 7 129 123 78 72 43 9 337
Ebrahim Kharazinejad Iran 9 144 1.1× 237 1.9× 68 0.9× 79 1.1× 25 0.6× 18 484
Shanshan Qin China 10 149 1.2× 166 1.3× 130 1.7× 96 1.3× 18 0.4× 32 480
Supannikar Tawinwung Thailand 9 134 1.0× 101 0.8× 50 0.6× 105 1.5× 14 0.3× 25 289
Xiaomei Zhang China 7 240 1.9× 312 2.5× 39 0.5× 201 2.8× 48 1.1× 14 604
Aleksandra Głogowska Canada 14 89 0.7× 244 2.0× 35 0.4× 47 0.7× 36 0.8× 25 512
Ezequiel Dantas Argentina 8 70 0.5× 181 1.5× 35 0.4× 125 1.7× 48 1.1× 16 414
Cosmin Lisencu Romania 9 114 0.9× 219 1.8× 36 0.5× 41 0.6× 11 0.3× 25 466
Ren-Yu Huang Taiwan 5 156 1.2× 142 1.2× 37 0.5× 169 2.3× 17 0.4× 8 372
Geoffrey Kuesters United States 10 126 1.0× 186 1.5× 85 1.1× 51 0.7× 21 0.5× 18 400
Ning Zeng China 12 77 0.6× 126 1.0× 141 1.8× 53 0.7× 26 0.6× 20 411

Countries citing papers authored by Natalie Mount

Since Specialization
Citations

This map shows the geographic impact of Natalie Mount's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Mount with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Mount more than expected).

Fields of papers citing papers by Natalie Mount

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Mount. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Mount. The network helps show where Natalie Mount may publish in the future.

Co-authorship network of co-authors of Natalie Mount

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Mount. A scholar is included among the top collaborators of Natalie Mount based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Mount. Natalie Mount is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ginty, Patrick, Gopalan V. Pillai, Gayatri Sharma, et al.. (2017). Preclinical development of an automated injection device for intradermal delivery of a cell-based therapy. Drug Delivery and Translational Research. 7(5). 695–708. 3 indexed citations
2.
Mount, Natalie, Stephen Ward, Panos Kefalas, & Johan Hyllner. (2015). Cell-based therapy technology classifications and translational challenges. Philosophical Transactions of the Royal Society B Biological Sciences. 370(1680). 20150017–20150017. 121 indexed citations
3.
Bisson, Isabelle, et al.. (2015). Landscape of Current and Emerging Cell Therapy Clinical Trials in the Uk: Current Status, Comparison to Global Trends and Future Perspectives. Regenerative Medicine. 10(2). 169–179. 11 indexed citations
4.
Sharpe, Michaela & Natalie Mount. (2015). Genetically modified T cells in cancer therapy: opportunities and challenges. Disease Models & Mechanisms. 8(4). 337–350. 119 indexed citations
5.
Feigal, Ellen G., Sowmya Viswanathan, Jiwen Zhang, et al.. (2014). Proceedings: International Regulatory Considerations on Development Pathways for Cell Therapies. Stem Cells Translational Medicine. 3(8). 879–887. 14 indexed citations
6.
Bungay, Peter J., et al.. (2011). Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist. Drug Metabolism and Disposition. 39(8). 1396–1405. 18 indexed citations
7.
Howe, David, Natalie Mount, Amy Brown, et al.. (2011). The Translational Efficacy of a Nonsteroidal Progesterone Receptor Antagonist, 4-[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on Endometrial Growth in Macaque and Human. Journal of Pharmacology and Experimental Therapeutics. 339(2). 642–653. 1 indexed citations
8.
Allerton, Charlotte, Chris Barber, Kevin Beaumont, et al.. (2006). A Novel Series of Potent and Selective PDE5 Inhibitors with Potential for High and Dose-Independent Oral Bioavailability. Journal of Medicinal Chemistry. 49(12). 3581–3594. 18 indexed citations
9.
Mount, Natalie, et al.. (2002). Selectivity of sildenafil and other phosphodiesterase type 5 (PDE5) inhibitors against all human phosphodiesterase families. European Urology Supplements. 1(1). 63–63. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026